Background: Our aim was to investigate longer-term surgical and quality of life (QOL) outcomes in a cohort of women undergoing robotic-assisted laparoscopic sacrocolpopexy (RALS) for pelvic organ prolapse (POP). Methods: We performed a retrospective cohort study at a single institution of female patients undergoing RALS with and without concomitant robotic-assisted laparoscopic hysterectomy, urethral sling, and rectocele repair. Scores from the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) surveys were used to evaluate QOL outcomes. Clinical improvement was defined by a decrease in a patient's PFDI and PFIQ postoperative score by ⩾70%. 
Introduction
Approximately 3% of women will have symptomatic pelvic organ prolapse (POP) in their lifetime, 1 and, in the United States alone, 200,000 surgical repairs for POP are performed annually. 2, 3 Defined as the descent of the vaginal cuff or cervix, apical vaginal prolapse can be associated with prolapse of the anterior and posterior vaginal compartment. In clinical practice, these anatomic changes are often associated with not only symptoms of vaginal bulging, but also with pelvic floor dysfunction symptoms, such as urinary urgency, incontinence, and obstruction. 4, 5 Symptoms related to bowel function are also commonly experienced, such as fecal incontinence and obstruction. 4, 5 Robotic-assisted laparoscopic sacrocolpopexy (RALS) is a commonly performed surgical procedure for apical POP. To address other associated pelvic floor symptoms, oftentimes, concomitant surgeries such as rectocele repair to address prolapse of the posterior compartment, and urethral sling placement to surgically treat or prophylactically occult prevent occult stress urinary incontinence (SUI).
The aim of our study was to investigate the longer-term quality of life (QOL) outcomes in terms of prolapse, bladder, and bowel symptoms in a cohort of women undergoing RALS for apical POP, with and without concomitant rectocele repair and distal urethral sling placement.
Materials and methods
We performed a retrospective analysis of all women undergoing RALS for symptomatic apical POP November 2010-June 2015 at a single institution by one female pelvic medicine and reconstructive surgery (FPMRS) fellowship-trained urologist. Demographic variables, initial history, preoperative and postoperative physical examination, and preoperative and postoperative QOL questionnaire data collection was collected.
Outcomes included objective data analysis obtained by Baden-Walker (B-W) preoperative POP grading and subjective data retrieved from self-reported QOL validated questionnaires administered preoperatively and postoperatively. Questionnaires were completed in the waiting room before the history and physical examination and without the influence of health care providers. The B-W grading system was used over the Pelvic Organ Prolapse Quantification (POP-Q) system due to the surgeon's preference. The B-W grading system consists of 4 grades: grade 0, no prolapse; grade 1, halfway to hymen; grade 2, to hymen; grade 3, halfway past hymen; and grade 4, maximum descent. 6 When assessing objective data by B-W grading, clinical improvement (clinical significance) was determined if there was no apical prolapse recurrence (grade 0/1).
Scores from the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) surveys were used to evaluate QOL outcomes. The Pelvic Floor Impact Questionnaire (PFIQ) and the Pelvic Floor Distress Inventory (PFDI) were selected because they represent a reliable and valid tool to assess QOL in women with pelvic floor disorder. [6] [7] [8] The PFDI is comprised of three subscales assessing the severity of symptoms related to prolapse (POPDI-6), colorectal (CRADI-8), and urinary (UDI-6) bother.
The PFIQ is also structured with three comparable subscales: prolapse, colorectal, and urinary symptoms. Each survey was evaluated by the total score (TS) range and their three respective subscales. 9 To assess the subjective outcomes, we calculated the improvement rate for each questionnaire. Clinical improvement was defined by a decrease in a patient's PFDI and PFIQ postoperative score by ⩾70%. We selected the improvement threshold of 70% or more to assess QOL data based on other studies that have used this cutoff when assessing validated questionnaires, such as the 2012 Value of Urodynamics Evaluation trial. [9] [10] [11] The American Urological Association (AUA) Symptom Score on QOL was also used, asking specifically, 'How would you feel if you had to live with your current condition for the rest of your life?' Higher scores represent worse QOL (range, 0-6). Questionnaires were completed in the waiting room before the history and physical examination, and without the influence of any health care provider.
Robotic sacrocolpopexy was performed using the Da Vinci Si robot (Intuitive, Sunnyvale, CA, USA) by a single fellowship-FPMRS-trained surgeon. We perform the RALS as previously described in Barboglio and colleagues. 10 Once the robotic arms are undocked, the fascia was closed at camera port site, and then skin was closed.
In patients with symptomatic SUI, or who desired a prophylactic procedure for occult SUI, a distal urethral polypropylene sling was placed. 12 Per surgeon preference, distal urethral sling, instead of a midurethral sling, was performed using the Raz technique to help prevent proximal migration and recurrent stress urinary incontinence. 12 Concomitant posterior compartment defect repairs were performed if present and symptomatic preoperatively Rectoceles were repaired via the midline, transvaginal approach. Hydrodissection was performed, and a vaginal midline epithelial incision made just past the proximal aspect to the rectocele. The epithelium was dissected off the rectovaginal tissue. The deficient rectovaginal fascia was repaired cranial to caudal, using interrupted polyglactin suture, with careful attention to avoid placating the levator muscles. Perineorrhaphy was then performed if indicated.
Patients were subsequently evaluated postoperatively at 2 weeks, and then at 3, 6, and 12 months, Table 1 . No significant differences were seen between these two groups, making the 179, with complete pre-and postoperative survey data, a representative sample.
Subjective data ( Subanalysis was performed to evaluate factors associated with those women who did, and did not, reach clinical improvement (⩾70% decrease) on both the PFDI and PFIQ TS. There were 33 patients who failed to improve in both questionnaires, and 146 who clinically improved in either the PFDI or PFIQ questionnaire. Table 3 illustrates the demographics of these two groups. Average age and a higher preoperative AUA symptom score were significantly different between the two groups (p = 0.010, 0.017, respectively). Logistic regression was performed with the odds ratio results also displayed in Table  3 . Only younger patient age (OR 0.92, p = 0.011) and a higher preoperative AUA QOL score (OR 1.42, p = 0.046) were still associated with clinical improvement.
When assessing the objective anatomical outcomes, we compared postoperative physical exam data between those who reached clinical significance for total score in both surveys versus and those who did not. There was no significant difference in the pre-and postoperative anatomic POP B-W grading between those who reached clinical significance and those who did not. Thus, there was no association between objective and subjective outcomes. of the PFIQ and the PFDI In both surveys; there were significantly fewer patients who reported an improvement in their bowel symptoms, compared with the pelvis and bladder symptoms.
Lastly, we compared rates of bowel symptom improvement in those who underwent rectocele repair compared with those who did not. As displayed in 
Discussion
There have been several studies assessing results after robotic sacrocolpopexy. 10,13,14 Gupta and colleagues showed only two apical recurrences in 196 women undergoing robotic prolapse repair, with a mean follow-up time of 9 months. 13 Other studies, too, have shown improvement in QOL scores using the PFDI and the PFIQ. [14] [15] [16] [17] [18] In a recently published study by Jong and colleagues, following robotic mesh sacrocolpopexy of 56 women with a mean follow-up time of 3 years, mean AUA QOL score improved significantly from a mean of 4-1.78 postoperatively. However, the mean UDI-6 score did not improve to a level of statistical significance (5-4.59, p = 0.40). 14 In a mean 12-month follow-up time, Geller and colleagues report a decrease in PFDI TS from 117 to 38, and a decrease in PFIQ TS from 60 to 10. However, this study did not report differences in individual subscores. 16 In their follow-up study from 2012, with a mean follow-up time of 44 months, PFDI TS increased back 61 and the PFIQ score increased to 19.1, reflecting worsening symptoms the further out from surgery. 19 Concomitant procedures were not reported in these studies. Paraiso and colleagues showed a decrease in 1-year postoperative PFDI TS to 44 from 128, with a dramatic decrease in prolapse score to 6 from 50, and a decrease in bowel subscore to 18 from 31, and urinary symptoms from 44 to 18. Interestingly, PFIQ score showed a drastic decrease to 0 from 63. 17 Our decision to perform a rectocele repair was based on clinical symptoms preoperatively (such as difficulty with defecation, rectal pressure, sense of incomplete rectal emptying after a bowel movement) and anatomic physical exam at the time of apical repair. Our concomitant rectocele repair rate of 24.4% is slightly higher than those reported in a 2014 meta-analysis of 13 studies, showing that 18.5% of patients have a rectocele repair at the time of robotic sacrocolpopexy. 15 However, in a Paraiso's cohort of 40 robotic sacrocolpopexy cases, rectocele was performed in 29% of patients. 17 The decision to place a prophylactic urethral sling at the time of sacrocolpopexy for occult SUI is well-supported by the results of the Pelvic Floor Disorders Network randomized control trial. 20 However, the decision to perform a prophylactic rectocele repair for asymptomatic posterior vaginal wall prolapse at the time of sacrocolpopexy has not yet been studied. The Pelvic Floor Society (TPFS) recently conducted a systematic review of evidence for the perioperative and long-terms benefits and harms of recto-vaginal reinforcement procedures, which concluded that the current available evidence was characterized almost exclusively by observational studies with poor methodological quality and heterogeneous findings. 21 This suggests that higher quality studies are needed to further investigate the symptomatic and QOL outcomes after rectocele repair.
The difference in postoperative bowel symptoms as compared with the prolapse and bladder symptoms was not as pronounced in our study. There have been other studies that show that the extent of the posterior vaginal prolapse does not correlate with the severity of symptoms. Gutman and colleagues showed in their cohort of 296 patients that the maximum vaginal decensus of 0 cm or more distal to the hymenal remnant was the threshold at which bulging and protrusion symptoms occur, but prolapse severity was not predictor of bowel symptoms based on the CRADI-8. 22 Interestingly, the severity of POP based on preoperative POP B-W grade was not associated with clinical improvement (⩾70% decrease) of survey scores. We did not find an association between POP grading system on either subjective or objective outcomes. However, we recognize that the POP-Q system of examination, not the B-W grading system, is the currently recommended physical examination grading system.
Limitations of our study include the retrospective nature of the study. We feel the fact that all procedures were performed by a single FPMRStrained surgeon using the same surgical technique is a strength, as well our longer-term follow-up. In addition, we did include a strict ⩾70% decrease in survey scores to define clinical significance. Minimally important differences in the urinary symptom subscores of the PFIQ and the PFDI have been reported, 23 but this data is not yet available for the subscores of the prolapse and bowel symptoms.
Currently there are no specific clinic guidelines from the AUA, Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) or the American Urogynecologic Society (AUGS) as to the surgical repair apical prolapse and the use of concomitant surgeries for the rectocele repair and SUI. While several studies have addressed the association of urinary and bowel symptoms with pelvic organ prolapse, 4,5,24 to our knowledge, this is the largest study of its kind to specifically assess postoperative bowel function symptoms, compared with prolapse and urinary symptoms, in patients who have undergone RALS with or without rectocele repair. In summary, most patients undergoing RALS saw clinical improvement overall. However, there were significantly fewer patients who reached clinical improvement with their bowel symptoms, compared with urinary and prolapse symptoms, regardless of concomitant rectocele repair. This suggests bowel dysfunction cannot be treated with anatomic repair alone, which can be helpful when counseling patients preoperatively regarding expectations of improving pre-existing bowel symptoms after sacrocolpopexy. 
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